Concepedia

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

Mark A. Socinski, Anastasia Ivanova, K. Bakri, J. Gerard Wall, Maria Q. Baggstrom, Thomas A. Hensing, A. Mears, Maureen Tynan, Jennifer L. Beaumont, Amy H. Peterman,

Annals of Oncology · 2005 · 42 citations · 19 references

DOIFull text

Open access

Concepts

References

19

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

David Cella, David S. Tulsky, Geoffrey V. Gray et al. · Journal of Clinical Oncology · 1993 · 6K citations

, , +15

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Joan H. Schiller, David Harrington, Chandra P. Belani et al. · New England Journal of Medicine · 2002 · 5K citations

, , +7

COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER

J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani et al. · 2002 · 3.7K citations

, , +11

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

S B Yellen, David Cella, Kimberly Webster et al. · Journal of Pain and Symptom Management · 1997 · 2K citations · Full text

, , +15

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell et al. · Journal of Clinical Oncology · 1989 · 1.9K citations

, , +17